Cargando…
Physician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
Despite the availability of predictive tools and treatment guidelines, anticoagulant therapies are underprescribed and many patients are undertreated for conditions that predispose to thromboembolic complications, including stroke. This review explores reasons for which physicians fear that the risk...
Autores principales: | Sen, Souvik, Dahlberg, Katherine Willett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Journal of the Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239310/ https://www.ncbi.nlm.nih.gov/pubmed/25285512 http://dx.doi.org/10.1097/MAJ.0000000000000349 |
Ejemplares similares
-
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007) -
Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021) -
How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
por: Schaefer, Jordan K., et al.
Publicado: (2015) -
Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients
With Nonvalvular Atrial Fibrillation
por: Kyriakou, Elias, et al.
Publicado: (2018) -
Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
por: Perreault, Sylvie, et al.
Publicado: (2019)